Sunday, November 15, 2020

Johnson & Johnson Starts 2-Dose Trial Of Covid Vaccine Candidate In UK

Johnson & Johnson launched a new late-stage trial in Britain on Monday to test a two-dose regimen of its experimental COVID-19 vaccine among thousands of volunteers, as the U.S. drugmaker expands its...

from NDTV News - Latest https://ift.tt/38NtXP0
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Amid Drug Price Cuts, A Look At India's Cancer Burden Against Asian Peers

India records around 1.56 million cancer cases and 9,02,000 deaths in 2025, making it the second-most affected country among selected Asian ...